Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-15-049914
Filing Date
2015-08-14
Accepted
2015-08-14 16:37:32
Documents
15
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A v418274_10q-a.htm 10-Q/A 274380
2 EXHIBIT 10.1 v418274_ex10-1.htm EX-10.1 536570
3 EXHIBIT 10.4 v418274_ex10-4.htm EX-10.4 30768
4 EXHIBIT 10.5 v418274_ex10-5.htm EX-10.5 227716
5 EXHIBIT 31.1 v418274_ex31-1.htm EX-31.1 10408
6 EXHIBIT 31.2 v418274_ex31-2.htm EX-31.2 10636
7 EXHIBIT 32.1 v418274_ex32-1.htm EX-32.1 4411
8 EXHIBIT 32.2 v418274_ex32-2.htm EX-32.2 4416
9 GRAPHIC tpg06.jpg GRAPHIC 99815
  Complete submission text file 0001144204-15-049914.txt   2735610

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT accp-20150630.xml EX-101.INS 215922
11 XBRL TAXONOMY EXTENSION SCHEMA accp-20150630.xsd EX-101.SCH 18550
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE accp-20150630_cal.xml EX-101.CAL 50767
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE accp-20150630_def.xml EX-101.DEF 62409
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE accp-20150630_lab.xml EX-101.LAB 273085
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE accp-20150630_pre.xml EX-101.PRE 155516
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-15771 | Film No.: 151056499
SIC: 2834 Pharmaceutical Preparations